Media Summary: Watch full interviews early, uncensored and ad-free as a Member - Watch this Full Interview: ... A former hedge fund manager whose drug company bought rights to a drug -- and then jacked up the price by 5000 percent ... Gravity Payments CEO Dan Price on Turing Pharmaceuticals CEO

Martin Shkreli On Raising Aids - Detailed Analysis & Overview

Watch full interviews early, uncensored and ad-free as a Member - Watch this Full Interview: ... A former hedge fund manager whose drug company bought rights to a drug -- and then jacked up the price by 5000 percent ... Gravity Payments CEO Dan Price on Turing Pharmaceuticals CEO After outrage over the price increase of Daraprim, a drug that helps treat An ex hedge fund manager has bought the rights to a drug and he is now price gouging those who need that drug to survive.

Photo Gallery

Martin Shkreli on Raising AIDS Drug from $14 to $750 Per Pill, Getting "Pharma Bro" Title (Part 9)
CEO defends raising drug price 5,000 percent
Martin Shkreli Who Raised Price Of AIDS Drug Indicted With Lawyer
CEO increases AIDS drug price by 5,000%
Martin Shkreli: The Drug Price Raising Pharmaceutical CEO Everyone Currently Hates
Martin Shkreli on Making Forbes 30 Under 30, Raising Drug Price from $1.50 to $30 Per Pill (Part 6)
Despite promise, pill cost has not dropped
Martin Shkreli must return $64M from Daraprim price hike | Top 10
Turing CEO defends 5,000% price increase on AIDS drug
Drug CEO Raises Price Of AIDS Medicine By 5000%
American Greed: CNBC Interviews Martin Shkreli About The Daraprim Price Hike | CNBC Prime
Martin Shkreli and the Price Gouging Pharma Industry: The Daily Desk | 80Twelve
Sponsored
Sponsored
View Detailed Profile
Martin Shkreli on Raising AIDS Drug from $14 to $750 Per Pill, Getting "Pharma Bro" Title (Part 9)

Martin Shkreli on Raising AIDS Drug from $14 to $750 Per Pill, Getting "Pharma Bro" Title (Part 9)

Watch full interviews early, uncensored and ad-free as a Member - https://www.youtube.com/vladtv/join Watch this Full Interview: ...

CEO defends raising drug price 5,000 percent

CEO defends raising drug price 5,000 percent

A former hedge fund manager whose drug company bought rights to a drug -- and then jacked up the price by 5000 percent ...

Sponsored
Martin Shkreli Who Raised Price Of AIDS Drug Indicted With Lawyer

Martin Shkreli Who Raised Price Of AIDS Drug Indicted With Lawyer

Martin Shkreli

CEO increases AIDS drug price by 5,000%

CEO increases AIDS drug price by 5,000%

Gravity Payments CEO Dan Price on Turing Pharmaceuticals CEO

Martin Shkreli: The Drug Price Raising Pharmaceutical CEO Everyone Currently Hates

Martin Shkreli: The Drug Price Raising Pharmaceutical CEO Everyone Currently Hates

CEO of Turing Pharmaceuticals

Sponsored
Martin Shkreli on Making Forbes 30 Under 30, Raising Drug Price from $1.50 to $30 Per Pill (Part 6)

Martin Shkreli on Making Forbes 30 Under 30, Raising Drug Price from $1.50 to $30 Per Pill (Part 6)

Watch full interviews early, uncensored and ad-free as a Member - https://www.youtube.com/vladtv/join Watch this Full Interview: ...

Despite promise, pill cost has not dropped

Despite promise, pill cost has not dropped

After outrage over the price increase of Daraprim, a drug that helps treat

Martin Shkreli must return $64M from Daraprim price hike | Top 10

Martin Shkreli must return $64M from Daraprim price hike | Top 10

The federal judge also barred

Turing CEO defends 5,000% price increase on AIDS drug

Turing CEO defends 5,000% price increase on AIDS drug

Turing Founder

Drug CEO Raises Price Of AIDS Medicine By 5000%

Drug CEO Raises Price Of AIDS Medicine By 5000%

An ex hedge fund manager has bought the rights to a drug and he is now price gouging those who need that drug to survive.

American Greed: CNBC Interviews Martin Shkreli About The Daraprim Price Hike | CNBC Prime

American Greed: CNBC Interviews Martin Shkreli About The Daraprim Price Hike | CNBC Prime

Hear

Martin Shkreli and the Price Gouging Pharma Industry: The Daily Desk | 80Twelve

Martin Shkreli and the Price Gouging Pharma Industry: The Daily Desk | 80Twelve

Former Turing Pharmaceuticals CEO

Martin Shkreli on Drug Price Hikes and Playing the World’s Villain

Martin Shkreli on Drug Price Hikes and Playing the World’s Villain

Martin Shkreli